Orion Pharma Drug Patent Portfolio
Orion Pharma owns 7 orange book drugs protected by 4 US patents with Comtan having the least patent protection, holding only 2 patents. And Stalevo 75 with maximum patent protection, holding 3 patents. Given below is the list of Orion Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500867 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa | 29 Jun, 2020 | Expired |
| US6797732 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa | 29 Jun, 2020 | Expired |
| US6599530 | Oral compacted composition comprising catechol derivatives | 14 Sep, 2018 | Expired |
| US5446194 | Pharmacologically active catechol derivatives | 19 Oct, 2013 | Expired |
Latest Legal Activities on Orion Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orion Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2004 | US6797732 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2004 | US6797732 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2004 | US6797732 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2004 | US6797732 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2004 | US6797732 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2004 | US6797732 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2004 | US6797732 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2004 | US6797732 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2004 | US6797732 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2004 | US6797732 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2004 | US6797732 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2004 | US6797732 |
|
Issue Notification Mailed
Critical
| 09 Sep, 2004 | US6797732 |
|
Issue Notification Mailed
Critical
| 09 Sep, 2004 | US6797732 |
|
Issue Notification Mailed
Critical
| 09 Sep, 2004 | US6797732 |
Orion Pharma's Family Patents
Orion Pharma Drug List
Given below is the complete list of Orion Pharma's drugs and the patents protecting them.
1. Comtan
Comtan is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6599530 | Oral compacted composition comprising catechol derivatives |
14 Sep, 2018
(6 years ago)
| Expired |
| US5446194 | Pharmacologically active catechol derivatives |
19 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Comtan's drug page
2. Stalevo 100
Stalevo 100 is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500867 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US6797732 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US5446194 | Pharmacologically active catechol derivatives |
19 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stalevo 100's drug page
3. Stalevo 125
Stalevo 125 is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500867 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US6797732 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US5446194 | Pharmacologically active catechol derivatives |
19 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stalevo 125's drug page
4. Stalevo 150
Stalevo 150 is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500867 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US6797732 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US5446194 | Pharmacologically active catechol derivatives |
19 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stalevo 150's drug page
5. Stalevo 200
Stalevo 200 is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500867 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US6797732 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US5446194 | Pharmacologically active catechol derivatives |
19 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stalevo 200's drug page
Explore Our Curated Drug Screens
6. Stalevo 50
Stalevo 50 is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500867 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US6797732 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US5446194 | Pharmacologically active catechol derivatives |
19 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stalevo 50's drug page
7. Stalevo 75
Stalevo 75 is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500867 | Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US6797732 | Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
29 Jun, 2020
(4 years ago)
| Expired |
| US5446194 | Pharmacologically active catechol derivatives |
19 Oct, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stalevo 75's drug page